{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T10:50:15Z","timestamp":1756810215813},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12872-017-0540-3","type":"journal-article","created":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T09:06:15Z","timestamp":1493370375000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Effect of ivabradine on cardiovascular outcomes in patients with stable angina: meta-analysis of randomized clinical trials"],"prefix":"10.1186","volume":"17","author":[{"given":"Hayelom Gebrekirstos","family":"Mengesha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berhe","family":"Weldearegawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pammala","family":"Petrucka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadese","family":"Bekele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mala George","family":"Otieno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraha","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,28]]},"reference":[{"issue":"2","key":"540_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cpcardiol.2009.10.002","volume":"35","author":"TA Gaziano","year":"2010","unstructured":"Gaziano TA, Biton A, Anand S, Abrahams-Gessel MS, Murphy A. Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol. 2010;35(2):72\u2013115. doi:\n10.1016\/j.cpcardiol.2009.10.002\n\n.","journal-title":"Curr Probl Cardiol"},{"key":"540_CR2","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","volume":"3","author":"CD Mathers","year":"2006","unstructured":"Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.","journal-title":"PLoS Med"},{"key":"540_CR3","first-page":"162","volume-title":"Global status report on noncommunicable diseases 2010","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011. p. 162."},{"key":"540_CR4","unstructured":"World Health Organization. Noncommunicable diseases country profiles 2011. Geneva: World Health Organization, 2011.207 p."},{"key":"540_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00392-010-0207-x","volume":"100","author":"JC Reil","year":"2011","unstructured":"Reil JC, Custodis F, Swedberg K, et al. Heart rate reduction in cardiovascular disease and therapy. Clin Res Cardiol. 2011;100:11\u20139.","journal-title":"Clin Res Cardiol"},{"key":"540_CR6","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/0002-8703(93)90128-V","volume":"125","author":"MW Gillman","year":"1993","unstructured":"Gillman MW, Kannel WB, Belanger A, D\u2019Agostino RB. Influence of heart rate on mortality among persons with hypertension: the Framingham study. Am Heart J. 1993;125:1148\u201354.","journal-title":"Am Heart J"},{"key":"540_CR7","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/0002-8703(87)90666-1","volume":"113","author":"WB Kannel","year":"1987","unstructured":"Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA. Heart rate andcardiovascular mortality: the Framingham study. Am Heart J. 1987;113:1489\u201394.","journal-title":"Am Heart J"},{"key":"540_CR8","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/eurheartj\/ehi190","volume":"26","author":"A Diaz","year":"2005","unstructured":"Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of rest-ing heart rate in patients with suspected or proven coronary artery disease. Eur Heart J. 2005;26:967\u201374.","journal-title":"Eur Heart J"},{"key":"540_CR9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","volume":"372","author":"K Fox","year":"2008","unstructured":"Fox K, Ford I, Steg PG, Tendera M, Ferrari R. Ivabradine for patients with stablecoronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL):a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:807\u201316.","journal-title":"Lancet"},{"key":"540_CR10","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","volume":"318","author":"N Freemantle","year":"1999","unstructured":"Freemantle N, Cleland J, Young P, et al. Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999;318:1730\u20137.","journal-title":"BMJ"},{"key":"540_CR11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(04)16980-8","volume":"364","author":"PA Poole-Wilson","year":"2004","unstructured":"Poole-Wilson PA, Lubsen J, Kirwan BA, et al. Effect of long acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomized controlled trial. Lancet. 2004;364:849\u201357.","journal-title":"Lancet"},{"key":"540_CR12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/NEJM199802193380807","volume":"338","author":"JD Parker","year":"1998","unstructured":"Parker JD, Parker JO. Nitrate therapy for stable angina pectoris. N Engl J Med. 1998;338:520\u201331.","journal-title":"N Engl J Med"},{"key":"540_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.phrs.2006.03.006","volume":"53","author":"D DiFrancesco","year":"2006","unstructured":"DiFrancesco D. Funny channels in the control of cardiac rhythm and mode of action of selective blockers. Pharmacol Res. 2006;53:399\u2013406.","journal-title":"Pharmacol Res"},{"key":"540_CR14","doi-asserted-by":"publisher","unstructured":"Fox K, Ford I, Steg PG, Tardif JC, Ferrari R for the SIGNIFY Investigators. Ivabradine in stable coronary artery disease without clinical heart failure. N Engl J Med 2014;371:1091-1099.","DOI":"10.1056\/NEJMoa1406430"},{"key":"540_CR15","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","volume":"376","author":"K Swedberg","year":"2010","unstructured":"Swedberg K, Komajda M, B\u00f6hm M, Borer JS, Ford I, Dubost-Brama A, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomized placebo-controlled study. Lancet. 2010;376:875\u201385.","journal-title":"Lancet"},{"key":"540_CR16","unstructured":"European Medicines Agency. EPAR summary for the public. Canary Wharf, London, UK: European Medicines Agency 2005: 1\u20134."},{"key":"540_CR17","unstructured":"U.S. Food and Drug Administration. FDA approves Corlanor to treat heart failure [Web Page]. Available from: \nhttp:\/\/www.fda.gov\/NewsEvents\/Nwsroom\/PressAnnouncements\/ucm442978.htm\n\n."},{"key":"540_CR18","doi-asserted-by":"publisher","unstructured":"Cammarano C, Silva M, Comee M, Donovan JL, Malloy MJ. Meta-analysis of ivabradine in patients with stable coronary artery disease with and without left ventricular dysfunction. ClinTher. 2016;38(2):387\u201395.","DOI":"10.1016\/j.clinthera.2015.12.018"},{"key":"540_CR19","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1167\/iovs.08-2659","volume":"50","author":"GC Demontis","year":"2009","unstructured":"Demontis GC, Gargini C, Paoli TG, et al. Selective Hcn1 channels inhibition by ivabradine in mouse rodphotoreceptors. Invest Ophthalmol Vis Sci. 2009;50:1948\u201355.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"540_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1054-3589(10)59003-3","volume":"59","author":"C Thollon","year":"2010","unstructured":"Thollon C, Vilaine JP. I (f) inhibition in cardiovascular diseases. Adv Pharmacol. 2010;59:53\u201392.","journal-title":"Adv Pharmacol"},{"key":"540_CR21","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"},{"key":"540_CR22","volume-title":"Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [internet]","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [internet]. Oxford: The Cochrane Collaboration; 2011. Available from: \nwww.cochranehandbook.org\n\n."},{"key":"540_CR23","unstructured":"Mengesha H, Weldearegawi B, Ghezu M, Bekelle T, George M. Effect of ivabradine on coronary artery disease: a systematic review and meta-analysis of randomized clinical trials. PROSPERO 2016:CRD42016035597 Available from \nhttp:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.asp?ID=CRD42016035597\n\n."}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-017-0540-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T09:06:28Z","timestamp":1493370388000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-017-0540-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,28]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["540"],"URL":"https:\/\/doi.org\/10.1186\/s12872-017-0540-3","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,28]]},"article-number":"105"}}